Infectious Disease Testing Product Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Cepheid, Abbott, OraSure Technologies Inc, Hologic Inc., BioFire Defense, Siemens Healthcare

The Infectious Disease Testing Product Market reached US$ 24.41 billion in 2023, rising to US$ 26.12 billion in 2024, and is expected to reach US$ 50.22 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

DataM Intelligence unveils its latest report on the "Infectious Disease Testing Products Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/infectious-disease-testing-products-market?sg

List of Top Key Player: F. Hoffmann-La Roche Ltd, Cepheid, Abbott, OraSure Technologies Inc., Hologic, Inc., BioFire Defense, Siemens Healthcare Private Limited, Avioq, Inc., QIAGEN, and Bio-Rad Laboratories, Inc.

United States - Industry Developments:

✅ Quest Diagnostics Launches Bird Flu Test
Quest Diagnostics is set to introduce a new test for H5N1 bird flu by the end of October 2024, following contracts from the U.S. Centers for Disease Control and Prevention (CDC) to support testing for H5N1 bird flu and Oropouche virus.

✅ Sherlock Bio Evaluates Over-the-Counter Rapid Test for STIs
Sherlock Bio has initiated a trial for its over-the-counter rapid test for detecting sexually transmitted infections (STI) such as chlamydia and gonorrhea, and aims to launch it by mid-2025.

✅ bioMérieux Acquires Day Zero Diagnostics
bioMérieux has announced an agreement to acquire the assets of Day Zero Diagnostics, a U.S.-based infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections.

✅ Advanced Instruments Acquires Nova Biomedical
In July 2025, Advanced Instruments, a subsidiary of Patricia Industries, completed the acquisition of Nova Biomedical for $2.2 billion, creating a stronger life sciences tools platform.

Japan - Industry Developments:

✅ Sysmex and QIAGEN Announce Exclusive Distribution Partnership
On October 1, 2025, Sysmex and QIAGEN announced an exclusive distribution partnership for diagnostic products in Japan, focusing on infectious disease and oncology clinical diagnostic instruments.

✅ Hitachi Partners with ELITech for Molecular Testing
On September 26, 2025, Hitachi announced a partnership with ELITech for the joint development of a fully automated PCR testing system for the diagnosis and monitoring of infectious diseases in Japan.

✅ Riken Genesis to Distribute ABL Diagnostics Infectious Disease Assays
Riken Genesis has been appointed to distribute ABL Diagnostics' infectious disease assays in Japan, expanding access to advanced diagnostic solutions.

South Korea - Industry Developments:

✅ Biotia Partners with Leading Korean Pharmaceutical Company
In July 2025, Biotia partnered with a leading Korean pharmaceutical company to advance infectious disease diagnostics in remote regions, including space applications.

✅ DKSH Acquires Molecular Diagnostics Korea Inc.
DKSH signed an agreement to acquire Molecular Diagnostics Korea Inc. (MDxK), strengthening its position in the South Korean life-science sector.

Europe - Industry Developments:

✅ Hitachi and ELITech Develop Automated PCR Testing System
On September 25, 2025, Hitachi and ELITech announced the joint development of a fully automated PCR testing system for infectious diseases, targeting the European market.

✅ Becton Dickinson to Merge with Waters Corporation
Becton Dickinson's biosciences and diagnostic solutions unit is set to merge with Waters Corporation in a $17.5 billion deal, expected to close in Q1 2026, enhancing their capabilities in molecular diagnostics.

✅ Tonix Pharmaceuticals to Participate in World Vaccine Congress Europe 2025
Tonix Pharmaceuticals announced its participation in the World Vaccine Congress Europe 2025, scheduled for October 9, 2025, to present and discuss advancements in vaccine development.

Forecast Projection:

The Global Infectious Disease Testing Products Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Infectious Disease Testing Products Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=infectious-disease-testing-products-market?sg

Key Segmentation:

By Product Type (Reagents, Consumables, and Instruments)

By Technology (Polymerase chain reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips and Microarrays, Mass Spectrometry, sequencing, and Others)

By Application (Respiratory Diseases, Tuberculosis, Meningitis, Human Papillomavirus, Hepatitis and Others)

By End User (Hospitals, Clinics, Diagnostics Laboratories, Research Institutes)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Infectious Disease Testing Products Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/infectious-disease-testing-products-market?sg

FAQ's

Q1: What is the current size of the Infectious Disease Testing Products Market and its future potential?

A: The Infectious Disease Testing Products Market was valued at US$ 26.12 billion in 2024 and is projected to surge to US$ 50.22 billion by 2033

Q2: How fast is the Infectious Disease Testing Products Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 7.5% between 2025 and 2032, signaling strong global growth and investment potential.

Q3: Which regions are dominating the Infectious Disease Testing Products Market and which are fastest-growing?

A: North America is expected to lead the global infectious disease testing product market.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.